Expression of concern
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Paper Information
Record ID:
35387
Author(s):
Publication Date:
June 21, 2021
Retraction Date:
February 07, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
- Evidence-based Medicine Consultancy, Bath, United Kingdom
- Emergency Department, Princess Elizabeth Hospital, Guernsey, United Kingdom
- Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, Northern Ireland, United Kingdom
Country:
🇬🇧 United KingdomArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1097/CND.0000000000000400Citations (236)
236
Total Citations160
Post-Retraction(67.8%)
76
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
11
Within 30 days
104
Within 1 year
28
After 2+ years
1234
Days since retraction (latest)
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients
Rémy Boussageon, Clara Blanchard, Élodie Charuel et al. (10 authors)
Therapies
Open Access
Published: Oct 2022
7 citations
7 citations
255 days after retraction
COVID-19 Treatment—Current Status, Advances, and Gap
C. M. Ho, Lee C
Pathogens
Open Access
Published: Oct 2022
8 citations
8 citations
253 days after retraction
Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future
Olayinka Ogunleye, Brian Godman, Joseph Fadare et al. (43 authors)
Vaccines
Open Access
Published: Sep 2022
41 citations
41 citations
222 days after retraction
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta-Cruz et al. (15 authors)
Life
Open Access
Published: Sep 2022
7 citations
7 citations
211 days after retraction
Perspective: repurposed Drugs for COVID-19
Kesara Na‐Bangchang, Supattra Porasuphatana, Juntra Karbwang
Archives of Medical Science
Open Access
Published: Aug 2022
7 citations
7 citations
204 days after retraction
Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis
Stephanie Weibel, Maria Popp, Stefanie Reis et al. (6 authors)
Research Synthesis Methods
Open Access
Published: Aug 2022
61 citations
61 citations
203 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal
Open Access
Published: Aug 2022
202 days after retraction
Treatments for the Infection by SARS-CoV-2
Nicolás Padilla-Raygoza, Gilberto Flores-Vargas, María de Jesús Gallardo-Luna et al. (6 authors)
IntechOpen eBooks
Open Access
Published: Aug 2022
201 days after retraction
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Anan Manomaipiboon, Kittisak Pholtawornkulchai, Sujaree Poopipatpab et al. (8 authors)
Trials
Open Access
Published: Aug 2022
11 citations
11 citations
200 days after retraction
Fragment-based design of SARS-CoV-2 Mpro inhibitors
Divya Teli, Bansari Patel, Mahesh T. Chhabria
Structural Chemistry
Open Access
Published: Aug 2022
13 citations
13 citations
198 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal
Open Access
Published: Aug 2022
192 days after retraction
Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data
Eleftherios Gkioulekas, Peter A. McCullough, Vladimir Zelenko
COVID
Open Access
Published: Aug 2022
1 citation
1 citation
192 days after retraction
Research Into Potential Therapies Against COVID-19, With Focus On Ivermectin
Reza Rezaie Khanghah
Unknown Journal
Open Access
Published: Aug 2022
191 days after retraction
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs
Nunzio Iraci, Carmelo Corsaro, Salvatore V. Giofrè et al. (10 authors)
Biomolecules
Open Access
Published: Jul 2022
4 citations
4 citations
173 days after retraction
Racialising diabetes
Colleen Fuller
Indian Journal of Medical Ethics
Open Access
Published: Jul 2022
171 days after retraction
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
Milena Soriano Marcolino, Karina Cardoso Meira, Nathália Sernizon Guimarães et al. (9 authors)
BMC Infectious Diseases
Open Access
Published: Jul 2022
33 citations
33 citations
166 days after retraction
Fostering New Scientific Networks in the COVID Era and Beyond
Mabruka Alfaidi, Hanrui Zhang, Suellen D. Oliveira
Arteriosclerosis Thrombosis and Vascular Biology
Open Access
Published: Jul 2022
2 citations
2 citations
164 days after retraction
The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial
Asaf Biber, Geva Harmelin, Dana Lev et al. (10 authors)
International Journal of Infectious Diseases
Open Access
Published: Jul 2022
28 citations
28 citations
151 days after retraction
IVERMECTIN IN THE TREATMENT OF COVID-19 DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Dewa Ayu Agus Sri Laksemi, I. KETUT TUNAS, I Putu Eka Widyadharma et al. (5 authors)
International Journal of Applied Pharmaceutics
Open Access
Published: Jul 2022
150 days after retraction
COVID 19: Airway Management and Pharmacological Strategies
Sonal Chandra, Aditi Narang, Pratiti Choudhuri et al. (4 authors)
Journal of Cardiac Critical Care TSS
Open Access
Published: Jul 2022
144 days after retraction
Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232.
Andrew Bryant, Theresa A Lawrie, Edmund J. Fordham et al. (4 authors)
American Journal of Therapeutics
Open Access
Published: Jul 2022
2 citations
2 citations
144 days after retraction
Ivermectin for preventing and treating COVID-19
Maria Popp, Stefanie Reis, Selina Schießer et al. (10 authors)
Cochrane library
Open Access
Published: Jun 2022
158 citations
158 citations
134 days after retraction
Ivermectin-Induced Acute Psychosis in Patients Infected With COVID-19 Pneumonia
Lokesh Goyal, Ramesh Pandit, Trupti Pandit et al. (6 authors)
Cureus
Open Access
Published: Jun 2022
3 citations
3 citations
134 days after retraction
Nanomaterials for Photocatalytic Degradations of Analgesic, Mucolytic and Anti-Biotic/Viral/Inflammatory Drugs Widely Used in Controlling SARS-CoV-2
Mahsa Ebrahimi, Omid Akhavan
Catalysts
Open Access
Published: Jun 2022
65 citations
65 citations
131 days after retraction
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen et al. (8 authors)
BMC Pharmacology and Toxicology
Open Access
Published: Jun 2022
15 citations
15 citations
131 days after retraction
Non-effectiveness of Ivermectin on Inpatients and Outpatients With COVID-19; Results of Two Randomized, Double-Blinded, Placebo-Controlled Clinical Trials
Mohammad Sadegh Rezai, Fatemeh Ahangarkani, Andrew Hill et al. (29 authors)
Frontiers in Medicine
Open Access
Published: Jun 2022
14 citations
14 citations
129 days after retraction
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari et al. (6 authors)
Virology Journal
Open Access
Published: Jun 2022
21 citations
21 citations
126 days after retraction
The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
Helen Onyeaka, Phemelo Tamasiga, Joy Onyinyechi Chionuma et al. (5 authors)
Clinical Epidemiology and Global Health
Open Access
Published: Jun 2022
6 citations
6 citations
121 days after retraction
Identifying and managing problematic trials: a Research Integrity Assessment (RIA) tool for randomized controlled trials in evidence synthesis
Stephanie Weibel, Maria Popp, Stefanie Reis et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2022
5 citations
5 citations
118 days after retraction
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava et al. (4 authors)
Expert Review of Anti-infective Therapy
Published: May 2022
3 citations
3 citations
108 days after retraction
Toxicity assessment of emamectin benzoate and its commercially available formulations in Pakistan by in vivo and in vitro assays
Ameena Mobeen, Qaiser M. Khan, Iqra Ishrat et al. (5 authors)
Food and Chemical Toxicology
Published: May 2022
9 citations
9 citations
101 days after retraction
Oxytocin, the panacea for long-COVID? a review
Phuoc-Tan Diep, Mohammed Chaudry, Adam Dixon et al. (5 authors)
Hormone Molecular Biology and Clinical Investigation
Open Access
Published: May 2022
9 citations
9 citations
98 days after retraction
Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols
Leila Larisa Medeiros Marques, Stéphani Caroline Beneti, C. Pinzon et al. (4 authors)
Brazilian Journal of Biology
Open Access
Published: May 2022
8 citations
8 citations
95 days after retraction
Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases
Yishan Liu, Tao Zhou, Jiajia Hu et al. (8 authors)
Frontiers in Microbiology
Open Access
Published: Apr 2022
19 citations
19 citations
80 days after retraction
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Raluca Dumache, Alexandra Enache, Ioana Macașoi et al. (10 authors)
Pathogens
Open Access
Published: Apr 2022
15 citations
15 citations
78 days after retraction
Fragment-Based Design of SARS-CoV-2 Mpro inhibitors
Divya Teli, Bansari Patel, Mahesh T. Chhabria
Research Square (Research Square)
Open Access
Published: Apr 2022
70 days after retraction
Unethical studies of ivermectin for covid-19
Gideon Meyerowitz‐Katz, Sarah Wieten, María de Jesús Medina Arellano et al. (4 authors)
BMJ
Published: Apr 2022
11 citations
11 citations
66 days after retraction
Association between Ivermectin treatment and mortality in Covid-19: A hospital-based case-control study
Ravikirti, Alok Ranjan, Rajdeep Porel et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Apr 2022
58 days after retraction
COVID-19 Drugs and Breastfeeding Update
Philip O. Anderson
Breastfeeding Medicine
Published: Apr 2022
3 citations
3 citations
58 days after retraction
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Gilmar Reis, Eduardo A.S.M. Silva, Daniela C.M. Silva et al. (27 authors)
New England Journal of Medicine
Open Access
Published: Mar 2022
212 citations
212 citations
51 days after retraction
Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status
Nirmeen A. Sabry, Yasser Fouad, Mohamed AbdAllah et al. (5 authors)
American Journal of Therapeutics
Published: Mar 2022
49 days after retraction
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
Brit Long, Summer Chavez, Brandon M Carius et al. (7 authors)
The American Journal of Emergency Medicine
Open Access
Published: Mar 2022
15 citations
15 citations
47 days after retraction
Chemical Bonding in Homogenous Catalysis – Seen Through the Eyes of Vibrational Spectroscopy
Elfi Kraka, Marek Freindorf
Elsevier eBooks
Published: Mar 2022
47 days after retraction
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
Aleksandra Barać, Michele Bartoletti, Özlem Kurt Azap et al. (15 authors)
Clinical Microbiology and Infection
Open Access
Published: Mar 2022
10 citations
10 citations
44 days after retraction
Can Anti-Parasitic Drugs Help Control COVID-19?
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei et al. (8 authors)
Future Virology
Open Access
Published: Mar 2022
7 citations
7 citations
42 days after retraction
Maoto, a traditional herbal medicine, for post-exposure prophylaxis for Japanese healthcare workers exposed to COVID-19: A single center study
Atsuko Nabeshima, Atsuhiko Sakamoto, Kaoru Iwata et al. (9 authors)
Journal of Infection and Chemotherapy
Open Access
Published: Mar 2022
8 citations
8 citations
42 days after retraction
Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis
Avi Bitterman, Caitlin Pestana Martins, Ahuva Cices et al. (4 authors)
JAMA Network Open
Open Access
Published: Mar 2022
11 citations
11 citations
42 days after retraction
Self portrait of a rural surgeon
Vijayaprasad Gopichandran
Indian Journal of Medical Ethics
Open Access
Published: Mar 2022
37 days after retraction
Cannulate, extubate, ambulate approach for extracorporeal membrane oxygenation for COVID-19
J.W. Awori Hayanga, Jahnavi Kakuturu, Ankit Dhamija et al. (7 authors)
Journal of Thoracic and Cardiovascular Surgery
Open Access
Published: Mar 2022
11 citations
11 citations
32 days after retraction
Lack of antiviral activity of probenecid in Vero E6 cells and Syrian golden hamsters: a need for better understanding of inter-lab differences in preclinical assays
Helen Box, Shaun H. Pennington, Edyta Kijak et al. (19 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2022
4 citations
4 citations
24 days after retraction
Quick Stats
Total Citations:
236
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025